Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision
Clin Pharmacol Ther
.
2023 Sep;114(3):507-510.
doi: 10.1002/cpt.2955.
Epub 2023 Jun 11.
Authors
Jackson Burton
1
,
Bilal Abuasal
2
,
Sagar Bachhav
3
,
Jamie Connarn
4
,
Josh Cosman
5
,
Neeraj Gupta
6
,
Jing Jing
7
,
Sarah Kim
8
,
Tao Long
6
,
Nadia Terranova
9
,
Karthik Venkatakrishnan
10
,
Jian Wang
11
,
Qi Liu
2
Affiliations
1
Clinical Pharmacology and Pharmacometrics, Biogen Inc., Cambridge, Massachusetts, USA.
2
Office of Clinical Pharmacology, Office of Translational Sciences, CDER, FDA, Silver Spring, Maryland, USA.
3
Clinical Pharmacology, AbbVie Inc., North Chicago, Illinois, USA.
4
Clinical Pharmacology, Modeling and Simulation, Amgen Inc., South San Francisco, California, USA.
5
Digital Sciences, Abbvie, Inc., North Chicago, Illinois, USA.
6
Quantitative Clinical Pharmacology, Takeda Development Center Americas, Inc. (TDCA), Lexington, Massachusetts, USA.
7
Clinical Pharmacology, Genentech, Inc., South San Francisco, California, USA.
8
Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
9
Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany.
10
EMD Serono Research and Development Institute, Inc., Billerica, Massachusetts, USA.
11
Oncology Regulatory Science Strategy & Excellence, AstraZeneca, Wilmington, Delaware, USA.
PMID:
37303106
DOI:
10.1002/cpt.2955
No abstract available
MeSH terms
Humans
Pharmacokinetics
Pharmacology*
Pharmacology, Clinical*
United States